{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:39:16Z","timestamp":1792611556987,"version":"4.5.0"},"reference-count":70,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>In 2015, the Canadian Vasculitis Research Network (CanVasc) created recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) in Canada. The current update aims to revise existing recommendations and create additional recommendations, as needed, based on a review of new available evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A needs assessment survey of CanVasc members informed questions for an updated systematic literature review (publications spanning May 2014 to September 2019) using Medline, Embase, and Cochrane. New and revised recommendations were developed and categorized according to the level of evidence and strength of each recommendation. The CanVasc working group used a 2-step modified Delphi procedure to reach &gt; 80% consensus on the inclusion, wording, and grading of each new and revised recommendation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eleven new and 16 revised recommendations were created and 12 original (2015) recommendations were retained. New and revised recommendations are discussed in detail within this document. Five original recommendations were removed, of which 4 were incorporated into the explanatory text. The supplementary material for practical use was revised to reflect the updated recommendations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The 2020 updated recommendations provide rheumatologists, nephrologists, and other specialists caring for patients with AAV in Canada with new management guidance, based on current evidence and consensus from Canadian experts.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.200721","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T16:21:46Z","timestamp":1600186906000},"page":"555-566","source":"Crossref","is-referenced-by-count":44,"title":["CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-616X","authenticated-orcid":false,"given":"Arielle","family":"Mendel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8234-3047","authenticated-orcid":false,"given":"Ellen","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodko","family":"Bakowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corisande","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-9210","authenticated-orcid":false,"given":"David A.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Carette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Clements-Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison H.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-6364","authenticated-orcid":false,"given":"Jan Willem","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dipchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navjot","family":"Dhindsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilani","family":"Famorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Fifi-Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-008X","authenticated-orcid":false,"given":"Louis-Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clode","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Noone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4523-8525","authenticated-orcid":false,"given":"Jean-Paul","family":"Makhzoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7353-7007","authenticated-orcid":false,"given":"Nataliya","family":"Milman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8951-5518","authenticated-orcid":false,"given":"Heather N.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Rh\u00e9aume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dax G.","family":"Rumsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer E.","family":"Towheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8976-0492","authenticated-orcid":false,"given":"Judith","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1954-2822","authenticated-orcid":false,"given":"Marinka","family":"Twilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Yacyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae S.M.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8614-6972","authenticated-orcid":false,"given":"Lillian B.","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Khalidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-9549","authenticated-orcid":false,"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"2022062114102485000_48.4.555.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"2022062114102485000_48.4.555.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150376"},{"key":"2022062114102485000_48.4.555.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206350"},{"key":"2022062114102485000_48.4.555.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209507"},{"key":"2022062114102485000_48.4.555.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.140"},{"key":"2022062114102485000_48.4.555.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905"},{"key":"2022062114102485000_48.4.555.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204164"},{"key":"2022062114102485000_48.4.555.8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12882-019-1226-0","article-title":"Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated vasculitis: a multi-center retrospective cohort study","volume":"20","author":"Chanouzas","year":"2019","journal-title":"BMC Nephrol"},{"key":"2022062114102485000_48.4.555.9","doi-asserted-by":"crossref","first-page":"105883","DOI":"10.1016\/j.intimp.2019.105883","article-title":"The effect of pulse methylprednisolone induction therapy in Chinese patients with dialysis-dependent MPO-ANCA associated vasculitis","volume":"76","author":"Huang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"2022062114102485000_48.4.555.10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s12879-019-4300-0","article-title":"Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"19","author":"Yamaguchi","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2022062114102485000_48.4.555.11","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/1756-185X.13662","article-title":"Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis, using a Japanese health insurance database","volume":"22","author":"Sakai","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2022062114102485000_48.4.555.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190019"},{"key":"2022062114102485000_48.4.555.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803537"},{"key":"2022062114102485000_48.4.555.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169"},{"key":"2022062114102485000_48.4.555.15","first-page":"CD003232","article-title":"Interventions for renal vasculitis in adults","volume":"1","author":"Walters","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2022062114102485000_48.4.555.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213277"},{"key":"2022062114102485000_48.4.555.17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208073"},{"key":"2022062114102485000_48.4.555.18","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-015-0208-y"},{"key":"2022062114102485000_48.4.555.19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007010090"},{"key":"2022062114102485000_48.4.555.20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/jcm9020455","article-title":"Inpatient burden and mortality of Goodpasture\u2019s syndrome in the United States: nationwide inpatient sample 2003-2014","volume":"9","author":"Kaewput","year":"2020","journal-title":"J Clin Med"},{"key":"2022062114102485000_48.4.555.21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214245"},{"key":"2022062114102485000_48.4.555.22","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11801018"},{"key":"2022062114102485000_48.4.555.23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm780"},{"key":"2022062114102485000_48.4.555.24","doi-asserted-by":"publisher","DOI":"10.1159\/000324364"},{"key":"2022062114102485000_48.4.555.25","doi-asserted-by":"crossref","unstructured":"Song GG , Lee YH . Comparative efficacy and safety of mycophenolate mofetil versus cyclophosphamide in patients with active antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of randomized trials. Z Rheumatol 2020 Apr 26 (E-pub ahead of print).","DOI":"10.1007\/s00393-020-00803-5"},{"key":"2022062114102485000_48.4.555.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404231"},{"key":"2022062114102485000_48.4.555.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212768"},{"key":"2022062114102485000_48.4.555.28","doi-asserted-by":"crossref","unstructured":"Smith R , Jayne D , Merkel PA . A randomized, controlled trial of rituximab versus azathioprine after induction of remission with rituximab for patients with ANCA-associated vasculitis and relapsing disease [abstract]. Arthritis Rheumatol 2019;71 Suppl 10.","DOI":"10.1093\/ndt\/gfaa146.LB004"},{"key":"2022062114102485000_48.4.555.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211281"},{"key":"2022062114102485000_48.4.555.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212878"},{"key":"2022062114102485000_48.4.555.31","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/art.39637","article-title":"Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3","volume":"68","author":"Fussner","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102485000_48.4.555.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu452"},{"key":"2022062114102485000_48.4.555.33","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40538","article-title":"Association between reappearance of myeloperoxidase-antineutrophil cytoplasmic antibody and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: Subgroup analysis of nationwide prospective cohort studies","volume":"70","author":"Watanabe","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102485000_48.4.555.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211123"},{"key":"2022062114102485000_48.4.555.35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/RHU.0000000000001030","article-title":"Evaluation of PR3-ANCA status after rituximab for ANCA-associated vasculitis","volume":"25","author":"McClure","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"2022062114102485000_48.4.555.36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/rheumatology\/key117","article-title":"Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients","volume":"58","author":"Pu\u00e9chal","year":"2019","journal-title":"Rheumatology"},{"key":"2022062114102485000_48.4.555.37","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.39450","article-title":"Long-term outcomes among participants in the WEGENT trial of remission-maintenance therapy for granulomatosis with polyangiitis (Wegener\u2019s) or microscopic polyangiitis","volume":"68","author":"Puechal","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102485000_48.4.555.38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jbspin.2013.11.006","article-title":"Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis","volume":"81","author":"Hazlewood","year":"2014","journal-title":"Joint Bone Spine"},{"key":"2022062114102485000_48.4.555.39","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv061"},{"key":"2022062114102485000_48.4.555.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607043350103"},{"key":"2022062114102485000_48.4.555.41","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw211"},{"key":"2022062114102485000_48.4.555.42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/M19-3827","article-title":"Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"173","author":"Charles","year":"2020","journal-title":"Ann Intern Med"},{"key":"2022062114102485000_48.4.555.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.03.003"},{"key":"2022062114102485000_48.4.555.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.04.022"},{"key":"2022062114102485000_48.4.555.45","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/art.40205","article-title":"Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg-Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial","volume":"69","author":"Pu\u00e9chal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102485000_48.4.555.46","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/rheumatology\/kez139","article-title":"Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial","volume":"58","author":"Pu\u00e9chal","year":"2019","journal-title":"Rheumatology"},{"key":"2022062114102485000_48.4.555.47","first-page":"177","article-title":"Efficacy of conventional immunosuppressants in relapsing or refractory eosinophilic granulomatosis with polyangiitis: evidence from a Canadian single-centre cohort","volume":"38","author":"Doubelt","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2022062114102485000_48.4.555.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079"},{"key":"2022062114102485000_48.4.555.49","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206095"},{"key":"2022062114102485000_48.4.555.50","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000905"},{"key":"2022062114102485000_48.4.555.51","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jaip.2017.07.027","article-title":"Rituximab as induction therapy in eosinophilic granulomatosis with polyangiitis refractory to conventional immunosuppressive treatment: a 36-month follow-up analysis","volume":"5","author":"Thiel","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2022062114102485000_48.4.555.52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez217"},{"key":"2022062114102485000_48.4.555.53","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151355"},{"key":"2022062114102485000_48.4.555.54","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001088"},{"key":"2022062114102485000_48.4.555.55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev129"},{"key":"2022062114102485000_48.4.555.56","doi-asserted-by":"crossref","unstructured":"Brogan P , Cleary G , O. HA , Kasapcopur O , Rangaraj S , Yeung R , Pediatric open-label clinical study of rituximab for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) [abstract]. Arthritis Rheumatol 2018;70 Suppl 10.","DOI":"10.1136\/annrheumdis-2018-eular.2150"},{"key":"2022062114102485000_48.4.555.57","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/art.40112","article-title":"Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Morishita","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102485000_48.4.555.58","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu372"},{"key":"2022062114102485000_48.4.555.59","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/art.39317","article-title":"Incidence of malignancies in patients with antineutrophil cytoplasmic antibody-associated vasculitis diagnosed between 1991 and 2013","volume":"67","author":"Rahmattulla","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102485000_48.4.555.60","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209925"},{"key":"2022062114102485000_48.4.555.61","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212861"},{"key":"2022062114102485000_48.4.555.62","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022062114102485000_48.4.555.63","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jbspin.2016.09.019","article-title":"Failure of pneumococcal immunization during remission induction treatment of ANCA-associated vasculitis: the Pneumovas Pilot 1 study","volume":"84","author":"Groh","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2022062114102485000_48.4.555.64","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12416"},{"key":"2022062114102485000_48.4.555.65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/jcm8050590","article-title":"Alternative-dose versus standard-dose trivalent influenza vaccines for immunocompromised patients: a meta-analysis of randomised control trials","volume":"8","author":"Lai","year":"2019","journal-title":"J Clin Med"},{"key":"2022062114102485000_48.4.555.66","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/ckj\/sfx014","article-title":"Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"10","author":"Shah","year":"2017","journal-title":"Clin Kidney J"},{"key":"2022062114102485000_48.4.555.67","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180784"},{"key":"2022062114102485000_48.4.555.68","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.40032","article-title":"Effect of continuous B cell depletion with rituximab on pathogenic autoantibodies and total IgG levels in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Cortazar","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022062114102485000_48.4.555.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.11.009"},{"key":"2022062114102485000_48.4.555.70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.autrev.2019.03.010","article-title":"Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: systematic literature review","volume":"18","author":"Wijetilleka","year":"2019","journal-title":"Autoimmun Rev"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.200721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T21:17:34Z","timestamp":1655846254000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.200721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.3899\/jrheum.200721"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.200721","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}